ArticleCancer cell international2025

Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.

Abdelhadi Boulifa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.